Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14607925rdf:typepubmed:Citationlld:pubmed
pubmed-article:14607925lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C0056184lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C0524828lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C1413206lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C1413240lld:lifeskim
pubmed-article:14607925lifeskim:mentionsumls-concept:C1999177lld:lifeskim
pubmed-article:14607925pubmed:issue10lld:pubmed
pubmed-article:14607925pubmed:dateCreated2003-11-10lld:pubmed
pubmed-article:14607925pubmed:abstractTextDefective expression of Fas leads to B cell autoimmunity, indicating the importance of this apoptotic pathway in eliminating autoreactive B cells. However, B cells with anti-self specificities occasionally escape such regulation in individuals with intact Fas, suggesting ways of precluding this apoptosis. Here, we examine whether coligation of the B cell Ag receptor (BCR) with the complement (C3)-binding CD21/CD19/CD81 costimulatory complex can enhance the escape of human B cells from Fas-induced death. This was warranted given that BCR-initiated signals induce resistance to Fas apoptosis, some (albeit not all) BCR-triggered events are amplified by coligation of BCR and the co-stimulatory complex, and several self Ags targeted in autoimmune diseases effectively activate complement. Using a set of affinity-diverse surrogate Ags (receptor-specific mAb:dextran conjugates) with varying capacity to engage CD21, it was established that BCR:CD21 coligation lowers the BCR engagement necessary for inducing protection from Fas apoptosis. Enhanced protection was associated with altered expression of several molecules known to regulate Fas apoptosis, suggesting a unique molecular model for how BCR:CD21 coligation augments protection. BCR:CD21 coligation impairs the generation of active fragments of caspase-8 via dampened expression of membrane Fas and augmented expression of FLIP(L). This, in turn, diminishes the generation of cells that would be directly triggered to apoptosis via caspase-8 cleavage of caspase 3 (type I cells). Any attempt to use the mitochondrial apoptotic protease-activating factor 1 (Apaf-1)-dependent pathway for apoptosis (as type II cells) is further blocked because BCR:CD21 coligation promotes up-regulation of the mitochondrial antiapoptotic molecule, Bcl-2.lld:pubmed
pubmed-article:14607925pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:languageenglld:pubmed
pubmed-article:14607925pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:citationSubsetAIMlld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14607925pubmed:statusMEDLINElld:pubmed
pubmed-article:14607925pubmed:monthNovlld:pubmed
pubmed-article:14607925pubmed:issn0022-1767lld:pubmed
pubmed-article:14607925pubmed:authorpubmed-author:FattahRasem...lld:pubmed
pubmed-article:14607925pubmed:authorpubmed-author:InmanJohn KJKlld:pubmed
pubmed-article:14607925pubmed:authorpubmed-author:JacksonAnna...lld:pubmed
pubmed-article:14607925pubmed:authorpubmed-author:MonginiPatric...lld:pubmed
pubmed-article:14607925pubmed:authorpubmed-author:TolaniSoniaSlld:pubmed
pubmed-article:14607925pubmed:issnTypePrintlld:pubmed
pubmed-article:14607925pubmed:day15lld:pubmed
pubmed-article:14607925pubmed:volume171lld:pubmed
pubmed-article:14607925pubmed:ownerNLMlld:pubmed
pubmed-article:14607925pubmed:authorsCompleteYlld:pubmed
pubmed-article:14607925pubmed:pagination5244-54lld:pubmed
pubmed-article:14607925pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
pubmed-article:14607925pubmed:meshHeadingpubmed-meshheading:14607925...lld:pubmed
More...